(Q38062322)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23178849%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

review article

1 reference

title

The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23178849%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author

Hanél Sadie-Van Gijsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23178849%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Nigel J. Crowther

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23178849%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

William Ferris

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23178849%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

F S Hough

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23178849%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

21 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23178849%20AND%20SRC:MED&resulttype=core&format=json

Cellular and Molecular Life Sciences

18 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23178849%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23178849%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23178849%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

2331-2349

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23178849%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00018-012-1211-2

18 February 2020

exact match

0 references

cites work

The bone-adipose axis in obesity and weight loss.

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Marrow fat and the bone microenvironment: developmental, functional, and pathological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

The function of adipocytes in the bone marrow stroma: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

PPARs in bone: the role in bone cell differentiation and regulation of energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Marrow fat metabolism is linked to the systemic energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

New factors controlling the balance between osteoblastogenesis and adipogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

PPARγ: a circadian transcription factor in adipogenesis and osteogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Reciprocal relation between marrow adiposity and the amount of bone in the axial and appendicular skeleton of young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

MRI-measured bone marrow adipose tissue is inversely related to DXA-measured bone mineral in Caucasian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Playing with bone and fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

The PPARgamma-selective ligand BRL-49653 differentially regulates the fate choices of rat calvaria versus rat bone marrow stromal cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Wnt signaling: a win for bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Fat and beyond: the diverse biology of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Instruction of mesenchymal cell fate by the transcription factor C/EBPβ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Retinoic acid-induced Smad3 expression is required for the induction of osteoblastogenesis of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Activation of CCAAT/enhancer-binding protein (C/EBP) alpha expression by C/EBP beta during adipogenesis requires a peroxisome proliferator-activated receptor-gamma-associated repression of HDAC1 at the C/ebp alpha gene promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Bone morphogenetic protein-2 stimulates adipogenic differentiation of mesenchymal precursor cells in synergy with BRL 49653 (rosiglitazone).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

BMP-2 and sonic hedgehog have contrary effects on adipocyte-like differentiation of C3H10T1/2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Sonic hedgehog is involved in osteoblast differentiation by cooperating with BMP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

The pro-osteogenic action of beta-catenin requires interaction with BMP signaling, but not Tcf/Lef transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

The organization, promoter analysis, and expression of the human PPARgamma gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

PPARgamma in human and mouse physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Distinct effects of PPARgamma insufficiency on bone marrow cells, osteoblasts, and osteoclastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Adipocytes decrease Runx2 expression in osteoblastic cells: roles of PPARγ and adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Depot-specific differences in the insulin response of adipose-derived stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

A PPARgamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

The peroxisome proliferator-activated receptors: ligands and activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Wnt signaling in osteoblasts and bone diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Regulation of bone mass by Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a β-catenin-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Regulation of osteoblastogenesis and bone mass by Wnt10b

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Gene array analysis of Wnt-regulated genes in C3H10T1/2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Sequential roles of Hedgehog and Wnt signaling in osteoblast development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Msx2 exerts bone anabolism via canonical Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Reciprocal roles of MSX2 in regulation of osteoblast and adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Depot-specific and hypercaloric diet-induced effects on the osteoblast and adipocyte differentiation potential of adipose-derived stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Molecular backgrounds of age-related osteoporosis from mouse genetics approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Skeletal aging and the adipocyte program: New insights from an "old" molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Nocturnin suppresses igf1 expression in bone by targeting the 3' untranslated region of igf1 mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Effect of estrogens on bone marrow adipogenesis and Sirt1 in aging C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

The effects of native and synthetic estrogenic compounds as well as vitamin D less-calcemic analogs on adipocytes content in rat bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Telomere maintenance genes SIRT1 and XRCC6 impact age-related decline in telomere length but only SIRT1 is associated with human longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Regulation of circulating sclerostin levels by sex steroids in women and in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Evolution of the Fgf and Fgfr gene families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Receptor recognition by gp130 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

GP130 cytokines and bone remodelling in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Interleukin-11: A novel stroma-derived cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Cardiotrophin-1 Is an Osteoclast-Derived Stimulus of Bone Formation Required for Normal Bone Remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Zinc finger protein 467 is a novel regulator of osteoblast and adipocyte commitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

The pathophysiology of the aging skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Vitamin D treatment of senescence accelerated mice (SAM-P/6) induces several regulators of stromal cell plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Vitamin D and adipogenesis: new molecular insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Glucocorticoid-induced osteoporosis: pathophysiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Bone marrow changes in adolescent girls with anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

The pituitary-adrenal axis and body composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Effects of dexamethasone on proliferation, activity, and cytokine secretion of normal human bone marrow stromal cells: possible mechanisms of glucocorticoid-induced bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Alkaline phosphatase is involved in the control of adipogenesis in the murine preadipocyte cell line, 3T3-L1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

The relationship between alkaline phosphatase activity and intracellular lipid accumulation in murine 3T3-L1 cells and human preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Role of ENPP1 on adipocyte maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Morphological and biochemical features of obesity are associated with mineralization genes' polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Relationships among body mass, its components, and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Relationship of obesity with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Differential effect of obesity on bone mineral density in White, Hispanic and African American women: a cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Racial differences in the association of subcutaneous and visceral fat on bone mineral content in prepubertal children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Bone mineral density in older non-Hispanic Caucasian and Mexican-American women: relationship to lean and fat mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Relationship between MRI-measured bone marrow adipose tissue and hip and spine bone mineral density in African-American and Caucasian participants: the CARDIA study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

The interrelationships between abdominal adiposity, leptin and bone mineral content in overweight Latino children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Lower bone mass in prepubertal overweight children with prediabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Visceral fat is a negative predictor of bone density measures in obese adolescent girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Adolescent obesity, bone mass, and cardiometabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Reciprocal relations of subcutaneous and visceral fat to bone structure and strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Relationship between visceral adiposity and bone mineral density in Korean adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Determinants of bone mineral density in obese premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Relationship between abdominal fat and bone mineral density in white and African American adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Impaired growth hormone secretion in the adult population: relation to age and adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

The Hormonal Activity of the Postmenopausal Ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Source of Estrogen Production in Postmenopausal Women1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Human fatty marrow aromatizes androgen to estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Aromatase in bone cell: association with osteoporosis in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

A possible role of estrone produced in adipose tissues in modulating postmenopausal bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Plasma Precursors of Estrogen. II. Correlation of the Extent of Conversion of Plasma Androstenedione to Estrone with Age1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Adiponectin, the controversial hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

AdipoQ is a novel adipose-specific gene dysregulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Adiponectin and its receptors are expressed in bone-forming cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

In vitro and in vivo effects of adiponectin on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Adiponectin is associated with bone mineral density in perimenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Serum adiponectin and bone mineral density in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Adiponectin as a novel determinant of bone mineral density and visceral fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Leptin deficiency--lessons in regional differences in the regulation of bone mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Leptin deficiency produces contrasting phenotypes in bones of the limb and spine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Skeletal phenotype of the leptin receptor-deficient db/db mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Leptin treatment prevents type I diabetic marrow adiposity but not bone loss in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Opposite effects of leptin on bone metabolism: a dose-dependent balance related to energy intake and insulin-like growth factor-I pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Serum leptin level is a regulator of bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Serum leptin level is a predictor of bone mineral density in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in post-menopausal Chinese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin,

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Getting the message across: mechanisms of physiological cross talk by adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

NEMO-binding domain peptide promotes osteoblast differentiation impaired by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

LPS-induced inhibition of osteogenesis is TNF-alpha dependent in a murine tooth extraction model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Enhanced bone formation in lipodystrophic PPARgamma(hyp/hyp) mice relocates haematopoiesis to the spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Elevated Fra-1 expression causes severe lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Clinical review#: Lipodystrophies: genetic and acquired body fat disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Computed tomography findings of congenital generalized lipodystrophy: multiple nodular fatty liver and diffuse sclerosis of bones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

High bone mass associated with berardinelli lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Endocrine regulation of energy metabolism by the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Increased bone formation in osteocalcin-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Carboxylation of osteocalcin affects its association with metabolic parameters in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1211-2

Bone marrow adipocytes: a neglected target tissue for growth hormone

21 January 2018

1 reference

12 December 2020

Aromatization of Androstenedione to Estrone by Human Adipose Tissue in Vitro. Correlation with Adipose Tissue Mass, Age, and Endometrial Neoplasia*

1 reference

12 December 2020

Relationship between body fat mass and bone metabolism

1 reference

12 December 2020

Modulation of growth factor incorporation into ECM of human osteoblast-like cells in vitro by 17 beta-estradiol

1 reference

12 December 2020

Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism

1 reference

12 December 2020

Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures

1 reference

12 December 2020

Excess androgenicity only partially explains the relationship between obesity and bone density in premenopausal women

1 reference

12 December 2020

Schnurri-2 Controls BMP-Dependent Adipogenesis via Interaction with Smad Proteins

1 reference

12 December 2020

Leptin receptor (OB-R) gene expression in human primary osteoblasts: confirmation

1 reference

12 December 2020

Local and systemic functions of bone fat and its contribution to the energy metabolism--the effect of diabetes and obesity on bone.

1 reference

12 December 2020

Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways

1 reference

12 December 2020

Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells

1 reference

12 December 2020

Fat conversion of femoral marrow in glucocorticoid-treated patients: a cross-sectional and longitudinal study with magnetic resonance imaging

1 reference

12 December 2020

Effects of aging and obesity on aromatase activity of human adipose cells

1 reference

12 December 2020

From mouse to man: redefining the role of insulin-like growth factor-I in the acquisition of bone mass.

1 reference

12 December 2020

Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway

1 reference

12 December 2020

Plasticity in adipogenesis and osteogenesis of human mesenchymal stem cells

1 reference

12 December 2020

Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation

1 reference

12 December 2020

Identification and Characterization of Growth Hormone Receptors on Isolated Rat Adipocytes

1 reference

12 December 2020

Expression of functional growth hormone receptors in cultured human osteoblast-like cells

1 reference

12 December 2020

In vivo and in vitro comparison of the effects of FGF-2 null and haplo-insufficiency on bone formation in mice

1 reference

12 December 2020

A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly

1 reference

12 December 2020

Roles of Wnt/beta-catenin signaling in adipogenic differentiation potential of adipose-derived mesenchymal stem cells

1 reference

12 December 2020

Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture

1 reference

12 December 2020

Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow.

1 reference

12 December 2020

Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women

1 reference

12 December 2020

Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta

1 reference

12 December 2020

Mechanical stress induces Interleukin-11 expression to stimulate osteoblast differentiation

1 reference

12 December 2020

Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation

1 reference

12 December 2020

Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women

1 reference

12 December 2020

Response of bipotential human marrow stromal cells to insulin-like growth factors: effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes

1 reference

12 December 2020

Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis

1 reference

12 December 2020

A myelosclerotic syndrome in mice engrafted with cells producing high levels of leukemia inhibitory factor (LIF)

1 reference

12 December 2020

Insulin-like effects of visfatin on human osteoblasts

1 reference

12 December 2020

Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects

1 reference

12 December 2020

Decreased AP-1 activity and interleukin-11 expression by bone marrow stromal cells may be associated with impaired bone formation in aged mice

1 reference

12 December 2020

1 reference

12 December 2020

Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization

1 reference

12 December 2020

Synthesis and Secretion of Insulin-Like Growth Factor and Its Binding Protein by the Perfused Rat Liver: Dependence on Growth Hormone Status*

1 reference

12 December 2020

Leptin signaling, adiposity, and energy balance

1 reference

12 December 2020

Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation

1 reference

12 December 2020

Prostaglandins regulate the expression of fibroblast growth factor-2 in bone

1 reference

12 December 2020

Glucocorticoid suppression of IGF I transcription in osteoblasts

1 reference

12 December 2020

The skeleton in congenital, generalized lipodystrophy: evaluation using whole-body radiographic surveys, magnetic resonance imaging and technetium-99m bone scintigraphy

1 reference

12 December 2020

Growth hormone stimulates proliferation of normal human bone marrow stromal osteoblast precursor cells in vitro.

1 reference

12 December 2020

In vitro effects of growth factors and dexamethasone on rat marrow stromal cells

1 reference

12 December 2020

Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone

1 reference

12 December 2020

Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins

1 reference

12 December 2020

Inhibition of PPARγ prevents type I diabetic bone marrow adiposity but not bone loss

1 reference

12 December 2020

Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome

1 reference

12 December 2020

Predictive Value of BMD for Hip and Other Fractures

1 reference

12 December 2020

Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression

1 reference

12 December 2020

Hormonal changes affect the bone and bone marrow cells in a rat model

1 reference

12 December 2020

Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor

1 reference

12 December 2020

VDR-mediated inhibition of DKK1 and SFRP2 suppresses adipogenic differentiation of murine bone marrow stromal cells

1 reference

12 December 2020

Interleukin-11 inhibits adipogenesis and stimulates myelopoiesis in human long-term marrow cultures

1 reference

12 December 2020

Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer

1 reference

12 December 2020

Insulin-like growth factors I and II: aging and bone density in women

1 reference

12 December 2020

Leukemia inhibitory factor influences the fate choice of mesenchymal progenitor cells

1 reference

12 December 2020

Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes

1 reference

12 December 2020

Biphasic effects of leukemia inhibitory factor on osteoblastic differentiation.

1 reference

12 December 2020

Reduced expression of interleukin-11 in bone marrow stromal cells of senescence-accelerated mice (SAMP6): relationship to osteopenia with enhanced adipogenesis

1 reference

12 December 2020

Isolation and characterization of insulin-like growth factor I (somatomedin-C) from cultures of fetal rat calvariae

1 reference

12 December 2020

Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2.

1 reference

12 December 2020

10.1007/S00018-012-1211-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23178849%20AND%20SRC:MED&resulttype=core&format=json

release_smj5cg7egbad7npp3kpkynpkwe

18 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/smj5cg7egbad7npp3kpkynpkwe

24 November 2022

mapped directly with Wikidata item

1 reference